Company: FORL
Filing Date: 2025-06-16
Form Type: DEF 14A
Source: 0001213900-25-054453
Chunk: 18

Company: Four Leaf Acquisition Corp
Filing Date: 2025-06-16
Form: DEF 14A
Chunk 18
---
287,500 founder shares, for no consideration, resulting in our Sponsor and directors continuing to hold 1,868,750 founder shares. On August 26, 2022, our Sponsor transferred 25,000 founder shares to each of Rahul Mewawalla and Stephen Markscheid, each of which are members of our Board. The awards will vest simultaneously with the closing of an initial business combination, provided the director has continuously served on our Board through the closing of such initial business combination. On March 22, 2023 (the “IPO Date”), we consummated our IPO. Pursuant to our IPO, we offered and sold an aggregate of 5,200,000 units (the “public units”). Each public unit consisted of one share of Class A common stock and one public warrant. Each public warrant entitles the holder thereof to purchase one share of Class A common stock at an exercise price of $11.50. The public units were sold at a price of $10.00 per unit, generating gross proceeds to us of $54,210,000. In connection with the consummation of the IPO, on March 16, 2023, our Sponsor forfeited an aggregate of 373,750 founder shares for no consideration, resulting in our Sponsor and directors holding an aggregate of 1,495,000 founder shares, of which up to 195,000 founder shares were subject to forfeiture to the extent the over -allotmentoption was not exercised in full by the underwriter prior to its expiration date on April 30, 2023. On March 17, 2023, the underwriters partially exercised their over -allotmentoption and purchased 221,000 additional public units. Upon the partial exercise their over -allotmentoption by the underwriters, the forfeiture lapsed for 55,250 founder shares. Following the expiration of the underwriters’ remaining over -allotmentoption on April 30, 2023, the remaining 139,750 founder shares were forfeited, resulting in our Sponsor and directors holding an aggregate of 1,355,250 founder shares. Simultaneously with the closing of the IPO, we consummated the private placement (“Private Placement”) of 3,576,900 warrants (the “private warrants”), which were purchased by our Sponsor, at a price of $1.00 per private warrant, generating gross proceeds to us of approximately $3.58 million. Upon the closing of the IPO and